XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Compensation Plan (Tables)
12 Months Ended
Dec. 31, 2023
Share-based Payment Arrangement [Abstract]  
Summary of Nonvested Restricted Shares
A summary of the status of the Company’s
non-vested
restricted shares as of December 31, 2021, 2022 and 2023, is presented below:
 
    
Number of
restricted
shares
    
Weighted average
grant date fair
value per
non-vested
share
 
Non-vested,
January 1, 2021
     —          —    
Granted
     343,744        2.99  
  
 
 
    
 
 
 
Non-vested,
December 31, 2021
  
 
343,744
 
  
 
2.99
 
  
 
 
    
 
 
 
Vested
     (171,872      2.99  
  
 
 
    
 
 
 
Non-vested,
December 31, 2022
  
 
171,872
 
  
 
2.99
 
  
 
 
    
 
 
 
Granted
     1,566,000        4.83  
  
 
 
    
 
 
 
Vested
     (620,872      3.08  
  
 
 
    
 
 
 
Non-vested,
December 31, 2023
     1,117,000     
 
5.52
 
  
 
 
    
 
 
 
Summary of the Company's non-vested stock option activity
A summary of the Company’s
non-vested
stock option activity and related information for the years ended December 31, 2021, 2022 and 2023, is as follows:
 
    
Option
shares #
    
Weighted-
Average

Exercise
Price $
 
Outstanding – January 1, 2021
     —         —   
Granted
     250,000        2.99  
Exercised
     —         —   
Outstanding – December 31, 2021
     250,000        2.99  
Exercisable – December 31, 2021
     —         —   
Granted
     —         —   
Exercised
     —         —   
Outstanding – December 31, 2022
     250,000        2.99  
Exercisable – December 31, 2022
     —         —   
Granted
     250,000        2.85  
Granted
     299,000        6.43  
Exercised
     (250,000      2.99  
Outstanding – December 31, 2023
  
 
549,000
 
  
 
4.80
 
Exercisable – December 31, 2023
     —         —